Clinical Trial Detail

NCT ID NCT02218606
Title Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

prostate cancer

Therapies

Cabazitaxel

Abiraterone + Prednisone

Age Groups: adult

No variant requirements are available.